Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
20.12
-0.49 (-2.38%)
Jul 11, 2025, 1:32 PM - Market open
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $647.06 million as of July 11, 2025. Its market cap has decreased by -13.61% in one year.
Market Cap
647.06M
Enterprise Value
332.68M
1-Year Change
-13.61%
Ranking
Category
Stock Price
$20.12
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $647.06M, an increase of 296.98%. That is a compound annual growth rate of 112.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 662.82M | 2.73% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |